Compositions including triciribine and methods of use thereof

A method for treating a subject having a tumor or cancer, which tumor or cancer overexpresses AKT kinase comprising:

• a. confirming whether the subject has a tumor or cancer that overexpresses AKT kinase and administering to said subject:
• i. at least one compound of formula I selected from the group consisting of the following compounds:
• wherein each R2′, R3′, and R5′ is independently hydrogen;
• optionally substituted phosphate or phosphonate;
• mono-, di-, or triphosphate;
• acyl;
• lower acyl;
• alkyl;
• lower alkyl;
• amide;
• sulfonate ester;
• alkyl sulfonate ester;
• arylalkyl sulfonate ester;
• sulfonyl;
• methanesulfonyl;
• benzyl sulfonyl, wherein the phenyl group of said benzyl is optionally substituted with one or more halo, hydroxyl, amino, alkylamino, arylamino, alkoxy, aryloxy, nitro, cyano, sulfonic acid, sulfate, phosphonic acid, phosphate, or phosphonate;
• optionally substituted arylsulfonyl;
• a lipid;
• phospholipid;
• an amino acid;
• a carbohydrate;
• a peptide;
• or cholesterol;
• or other pharmaceutically acceptable leaving group that, in vivo, provides a compound of said formula I wherein R2′, R3′ or R5′ is independently H or mono-, di- or tri-phosphate;
• wherein Rx and Ry are independently hydrogen;
• optionally substituted phosphate;
• acyl;
• lower acyl;
• amide;
• alkyl;
• lower alkyl;
• aromatic;
• polyoxyalkylene;
• polyethyleneglycol;
• optionally substituted arylsulfonyl;
• a lipid;
• a phospholipid;
• an amino acid;
• a carbohydrate;
• a peptide;
• or cholesterol;
• or other pharmaceutically acceptable leaving group;
• and
• wherein R1 and R2 each are independently H, optionally substituted straight chained, branched or cyclic alkyl, lower alkyl, alkenyl, or alkynyl, CO-alkyl, CO-alkenyl, CO-alkynyl, CO-aryl or heteroaryl, CO-alkoxyalkyl, CO-aryloxyalkyl, CO-substituted aryl, sulfonyl, alkylsulfonyl, arylsulfonyl, or aralkylsulfonyl;
• ii. trastuzumab or a salt thereof;
• and
• iii. a pharmaceutically acceptable carrier.